AMBELVIST
GADOQUATRANE 257.9 MG
Company: BAYER INC
Authorization date:
Data pulled:
Therapeutic class V08CA13 GADOQUATRANE did not match one condition rule, so the condition is Unclassified.
- DIN: 02570424
- Drug code: 107257
- DPD status: Approved
- Therapeutic class: V08CA13 GADOQUATRANE
SIMTRIYO
CENTANAFADINE HYDROCHLORIDE 280MG
Sponsor: OTSUKA PHARMACEUTICAL CO LTD
Approval date:
Data pulled:
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
- Application: NDA218145
- Submission class: Type 1 - New Molecular Entity
- Marketing status: Prescription
- Dosage form: CAPSULE, EXTENDED RELEASE
JIDEYTRO
ZIDESAMTINIB 25MG; ZIDESAMTINIB 100MG
Sponsor: NUVALENT
Approval date:
Data pulled:
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
- Application: NDA220185
- Submission class: Type 1 - New Molecular Entity
- Marketing status: Prescription
- Dosage form: TABLET
- Route: ORAL
- Submission property: Orphan
VUEWAY
GADOPICLENOL 485.1 MG
Company: BRACCO IMAGING CANADA
Original market date:
Data pulled:
Therapeutic class V08CA12 GADOPICLENOL did not match one condition rule, so the condition is Unclassified.
- DIN: 02567334
- Drug code: 106975
- DPD status: Marketed
- Therapeutic class: V08CA12 GADOPICLENOL
MRESVIA
*RSV F-PROTEIN MRNA, 5'(M7G-5'-PPP-5'-GM), 3'POLYA 50 MCG
Company: MODERNA BIOPHARMA CANADA CORPORATION
Original market date:
Data pulled:
Therapeutic class J07BX05 RESPIRATORY SYNCYTIAL VIRUS VACCINE did not match one condition rule, so the condition is Unclassified.
- DIN: 02552914
- Drug code: 104187
- DPD status: Marketed
- Therapeutic class: J07BX05 RESPIRATORY SYNCYTIAL VIRUS VACCINE
SLENYTO
MELATONIN 1 MG; MELATONIN 5 MG
Company: NEURIM PHARMACEUTICALS LTD.
Original market date:
Data pulled:
Therapeutic class N05CH01 MELATONIN did not match one condition rule, so the condition is Unclassified.
- DIN: 02560798, 02560801
- Drug code: 106382, 106383
- DPD status: Marketed
- Therapeutic class: N05CH01 MELATONIN
LIPFENDRA
ENLICITIDE DECANOATE EQ 20MG BASE
Sponsor: MSD
Approval date:
Data pulled:
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
- Application: NDA220848
- Submission class: Type 1 - New Molecular Entity
- Marketing status: Prescription
- Dosage form: TABLET
- Route: ORAL
LYNKUET
ELINZANETANT 60 MG
Company: BAYER INC
Original market date:
Data pulled:
Therapeutic class G02CX07 ELINZANETANT did not match one condition rule, so the condition is Unclassified.
- DIN: 02559714
- Drug code: 106284
- DPD status: Marketed
- Therapeutic class: G02CX07 ELINZANETANT
REVTORPYK
GEDATOLISIB 180MG/VIAL
Sponsor: CELCUITY
Approval date:
Data pulled:
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
- Application: NDA219908
- Submission class: Type 1 - New Molecular Entity
- Marketing status: Prescription
- Dosage form: POWDER
- Route: INTRAVENOUS
SCENESSE
AFAMELANOTIDE (AFAMELANOTIDE ACETATE) 16 MG
Company: CLINUVEL, INC.
Authorization date:
Data pulled:
Therapeutic class D02BB02 AFAMELANOTIDE did not match one condition rule, so the condition is Unclassified.
- DIN: 02569825
- Drug code: 107203
- DPD status: Approved
- Therapeutic class: D02BB02 AFAMELANOTIDE
JOENJA
LENIOLISIB (LENIOLISIB PHOSPHATE) 70 MG
Company: PHARMING TECHNOLOGIES B.V.
Authorization date:
Data pulled:
Therapeutic class L03AX22 LENIOLISIB did not match one condition rule, so the condition is Unclassified.
- DIN: 02569809
- Drug code: 107201
- DPD status: Approved
- Therapeutic class: L03AX22 LENIOLISIB
TRUTAKNA
ATACICEPT-VYMJ 150MG/ML
Sponsor: VERA THERAPEUTICS INC.
Approval date:
Data pulled:
Drugs@FDA did not include an indication on this record, so the condition is Unclassified.
- Application: BLA761486
- Submission class: Type 1 - New Molecular Entity
- Marketing status: Prescription
- Dosage form: INJECTABLE
- Route: SUBCUTANEOUS
KISUNLA
DONANEMAB 17.5 MG
Company: ELI LILLY CANADA INC
Original market date:
Data pulled:
Therapeutic class N06DX05 DONANEMAB did not match one condition rule, so the condition is Unclassified.
- DIN: 02567725
- Drug code: 107011
- DPD status: Marketed
- Therapeutic class: N06DX05 DONANEMAB